Gefjon Pharma ApS

Private limited companyCVR 44512971København NActive

Gefjon Pharma ApS is a private limited company, based in København N, active in manufacture of pharmaceutical preparations, founded in 2023. Equity was negative at the end of 2026 (−DKK 5m). The company made a loss in both 2025 and 2026, most recently DKK 4.2m. 8 other companies in the database are registered at the same address.

PDF report Compare

Key figures · financial year 2026

Gross profit−DKK 2.2m−575% vs. 2025

Net profit−DKK 4.2m−2,071.5% vs. 2025

Equity−DKK 5m−3,114.3% vs. 2025

Employees6latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2026 against 2025

Gross profit fell 575% (2025 → 2026), to −DKK 2.2m.
The loss grew: from DKK 196k to DKK 4.2m (2025 → 2026).

Employees

1 more employees than a year earlier: 6 (07/2026) against 5 (07/2025).

Management and owners, last 24 months

New in management: Thomas Frees Buthler (director, 27/01/2025), Anders Miki Bojesen (director, 27/01/2025) and Fabio Antenucci (director, 27/01/2025) (+4).

Registrations, last 24 months

29/04/2025: Moved to Ole Maaløes Vej 3, 2200 København N

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2025–2026 · amounts in DKK thousand

Equity and net profit

EquityNet profit

Financial figures for Gefjon Pharma ApS
	2025	2026	Change
Revenue	not stated	not stated	–
Gross profit	470	−2,230	−575%
Operating profit (EBIT)	−248	−4,402	−1,675.5%
Profit before tax	−248	−5,065	−1,943.7%
Net profit	−196	−4,245	−2,071.5%
Total assets	5,331	7,868	+47.6%
Equity	−156	−4,998	−3,114.3%
Liabilities	5,487	12,866	+134.5%
Cash and cash equivalents	4,291	6,963	+62.3%
Average number of employees	0	5	–

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2025, 2026: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

Compare with the industry (59 companies)

Gross profitMedian, the industry (59 companies)

Signals from the financial statements

calculated from the 2026 figures

Negative equity
Equity was −DKK 5m at the end of 2026.
How is this calculated?
Equity in the latest annual report is below zero.
Loss for 2 years in a row
Net result has been negative in 2025–2026.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

2 financial years

Annual reports for Gefjon Pharma ApS
Financial year	Period	Published	Figures for	Documents
2026	01/04/2025 – 31/03/2026	14/08/2026	The company	PDF not statedXBRL
2025	19/12/2023 – 31/03/2025	03/10/2025	The company	PDF not statedXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR

Employees

Position in the industry

59 companies in the database

Comparison with the other companies in manufacture of pharmaceutical preparations based on the latest financial year.

Gross profit−DKK 2.2mNo. 43 of 57

Better than 25% of the companies in the industry

Equity−DKK 5mNo. 49 of 59

Better than 17% of the companies in the industry

Number of employees6No. 33 of 59

Better than 45% of the companies in the industry

Industry median: gross profit DKK 2.8m, net profit −DKK 2.2m, equity DKK 5.2m, 10 employees.

Distribution of gross profit for 34 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form

Rank among similar companies
Group	Gross profit	Equity
Companies with fewer than 20 employees69,967 companies in the comparison	No. 69,239of 69,742 Better than 1%	No. 69,168of 69,964 Better than 1%
Same industry and fewer than 20 employees37 companies in the comparison	No. 25of 36 Better than 31%	No. 30of 37 Better than 19%
Companies that are founded within the last five years16,675 companies in the comparison	No. 16,455of 16,627 Better than 1%	No. 16,503of 16,674 Better than 1%
All companies of type ApS66,508 companies in the comparison	No. 65,969of 66,379 Better than 1%	No. 65,710of 66,505 Better than 1%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Manufacture of pharmaceutical preparations

Gross profit

Gefjon Pharma ApS−DKK 2.2m
Novo Nordisk A/SDKK 250.3bn
H. Lundbeck A/SDKK 20.4bn

Net profit

Gefjon Pharma ApS−DKK 4.2m
Novo Nordisk A/SDKK 102.4bn
H. Lundbeck A/SDKK 3.2bn

Equity

Gefjon Pharma ApS−DKK 5m
Novo Nordisk A/SDKK 194bn
H. Lundbeck A/SDKK 24.9bn

Employees

Gefjon Pharma ApS6
Novo Nordisk A/S27,279
H. Lundbeck A/S2,261

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register

Owners

Copenhagen Equity ApS25%
North2k ApS25%
TBU Holding 2023 ApS25%
Havito As25%

Gefjon Pharma ApS

Management

8 active registrations

Executive management

Executive management at Gefjon Pharma ApS
Name	Role	Appointed
Torben Hald	CEO	01/09/2024
Thomas Frees Buthler	Director	27/01/2025
Anders Miki Bojesen	Director	27/01/2025
Fabio Antenucci	Director	27/01/2025

Board of directors

Board of directors at Gefjon Pharma ApS
Name	Role	Appointed
Thomas Frees Buthler	Board member	03/02/2026
Anders Miki Bojesen	Chair of the board	03/02/2026
Torben Hald	Board member	03/02/2026
Fabio Antenucci	Board member	03/02/2026

Auditor: Pricewaterhousecoopers Statsautoriseret Revisionspartnerselskab
Founders: Copenhagen Equity ApS, North2k ApS, TBU Holding 2023 ApS, Havito As

Former management (1)

Former management at Gefjon Pharma ApS
Name	Role	Appointed	Resigned
Thomas Frees Buthler	Director	19/12/2023	23/09/2024

Signing rule: Selskabet tegnes af 2 direktører i forening eller af den samlede bestyrelse.

Address and production units

1 active production units

Ole Maaløes Vej 3
2200 København N

København Municipality · Postcode 2200

Other companies at the address (8)

BII Holdings A/SOther financial service activities n.e.c.
Skape Bio ApSResearch and experimental development on natural sciences and engineering
Agrobiomics ApSResearch and experimental development on natural sciences and engineering
Tetrakit Technologies ApSResearch and experimental development on natural sciences and engineering
BioColor ApSResearch and experimental development on natural sciences and engineering

Production units
Production unit	Address	Industry	Employees	P number
Gefjon Pharma ApS	Ole Maaløes Vej 3, 2200 København N	Manufacture of pharmaceutical preparations	6	1029939361

Purpose

Selskabets formål er at drive virksomhed med udvikling, produktion og salg af lægemidler til levnedsmiddelindustrien samt enhver anden aktivitet, som efter ledelsens skøn står i forbindelse hermed.

The purpose is quoted from the register in Danish.

Changes year by year

19 registered events

62023

32024

52025

52026

20265 changesaccounts 1 · management 4

14/08AccountsAnnual report for 2026 published
03/02ManagementTorben Hald appointed board member
03/02ManagementThomas Frees Buthler appointed board member
03/02ManagementAnders Miki Bojesen appointed chair of the board
03/02ManagementFabio Antenucci appointed board member

20255 changesaccounts 1 · address 1 · management 3

03/10AccountsAnnual report for 2025 published
29/04AddressMoved to Ole Maaløes Vej 3, 2200 København N
27/01ManagementFabio Antenucci appointed director
27/01ManagementThomas Frees Buthler appointed director
27/01ManagementAnders Miki Bojesen appointed director

20243 changesaddress 1 · management 2

23/09AddressMoved to Thorvaldsensvej 57, 1871 Frederiksberg C
23/09ManagementThomas Frees Buthler stepped down as director
01/09ManagementTorben Hald appointed ceo

20236 changesfounded 1 · management 1 · ownership 4

19/12FoundedRegistered as Gefjon Pharma ApS
19/12ManagementThomas Frees Buthler appointed director
19/12OwnershipCopenhagen Equity ApS registered as owner (25%)
19/12OwnershipNorth2k ApS registered as owner (25%)
19/12OwnershipTBU Holding 2023 ApS registered as owner (25%)
19/12OwnershipHAVITO AS registered as owner (25%)

Related companies

Same industry in København

H. Lundbeck A/S2,261 employees
AJ Vaccines A/S499 employees
Tetra Pharm Technologies ApS39 employees
Motilitycount ApS29 employees
Freya Biosciences ApS18 employees
Zerion Pharma A/S15 employees

See all →

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVR Report a correction